Epigenetics: A new link between nutrition and cancer

Nutrition and Cancer

Volumn 65, Issue 6, 2013, Pages 781-792

  Supic, Gordana ^a   Jagodic, Maja ^b   Magic, Zvonko ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BUTYRIC ACID; CURCUMIN; DIALLYL DISULFIDE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EPIGALLOCATECHIN GALLATE; FOLIC ACID; GENISTEIN; HISTONE; MICRORNA; QUERCETIN; RESVERATROL; SELENIUM; SULFORAPHANE;

ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DIET THERAPY; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; ESOPHAGUS CANCER; GENE EXPRESSION; GENE SILENCING; GENETIC SUSCEPTIBILITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HUMAN; LIVER CELL CARCINOMA; MOUTH CARCINOMA; NEOPLASM; NONHUMAN; NUTRITION; PROSTATE CANCER; PROTEIN PROCESSING; SPECIES DIFFERENCE; TEA; TISSUE SPECIFICITY; TRANSGENE; UVEA MELANOMA;

EID: 84882417921     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.805794     Document Type: Article

References (105)

1. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Eng J Med 349, 2042-2054, 2003.
2. Tollefsbol T: Cancer Epigenetics.CRCPress/Taylor&Francis Group, Boca Raton, FL, 2009.
3. Szyf M: DNA Methylation and Cancer Therapy. New York, NY: Kluwer Academic/Plenum Publishers, 2005.
4. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, et al. DNA methylation differences after exposure to prenatal famine are common and timing and sex-specific. Hum Mol Genet 18, 4046-4053, 2009.
5. Hughes LA, van den Brandt PA, de Bruïne AP, Wouters KA, Hulsmans S, et al.: Early life exposure to famine and colorectal cancer risk: A role for epigenetic mechanisms. PLoS One 4, e7951, 2009.
6. Heijmans B, Tobi E, Stein A, Putter H, Blauw G, et al.: Persistent epigenetic differences associated with prenatal exposure to famine in humans. PNAS 105, 17046-17049, 2008.
7. Zhang J, Zhang F, Didelot X, Bruce KD, Cagampang FR, et al.: Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics 10, 478-489, 2009.
8. Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 4, 988-993, 2004.
9. Jirtle R and Skinner M: Nature Genetics Review 8, 253-262, 2007.
10. Wolff GL, Kodell RL, Moore SR, and Cooney CA: Maternal epigenetics andmethyl supplements affect agouti gene expression inAvy/amice. FASEB J 12, 949-957, 1998.
11. Waterland RA and Jirtle RL: Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23, 5293-5300, 2003.
12. AnwayMD, Leathers C, and SkinnerMK: Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147, 5515-5523, 2006.
13. Yoon J and Baek S: Molecular targets of dietary polyphenols with antiinflammatory properties. Yonsei Med J 46, 585-596, 2005.
14. Yang C, Landau J, Huang M, and Newmark H: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21, 381-406, 2001.
15. KimY: Folate and carcinogenesis: Evidence, mechanisms, and implications. J Nutr Biochem 10, 66-88, 1999.
16. van den Donk M, Pellis L, Crott J, van EngelandM, Friederich P, et al.: Folic acid and vitamin b-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa dna of subjects with previous colorectal adenomas. J Nutr 137, 2114-2120, 2007.
17. Duthie SJ, Narayanan S, Blum S, Pirie L, and Brand GM: Folate deficiency in vitro induces uracil misincorporation,DNAhypomethylation and inhibits DNA excision repair in immortalised normal human colon epithelial cells. Nutr Cancer 37, 127-133, 2000.
18. Kim YI: Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13, 511-519, 2004.
19. van England M, Weijenberg MP, Roemen GMJM, Brink M, de Bruine AP, et al.: Effects of folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands Cohort Study on Diet and Cancer. Cancer Res 63, 3133-3137, 2003.
20. Trasler J, Deng L, Melnyk S, Pogribny I, Hiou-Tim F, et al.: Impact of DNMT1 deficiency with and without low folate diets on tumor numbers and DNA methylation in Min mice. Carcinogenesis 24, 39-45, 2003.
21. Giovannucci E, Stampfer M, Colditz G, Hunter D, Fuchs C, et al.: Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129, 517-524, 1998.
22. Sanjoaquin M, Allen N, Couto E, Roddam A, and Key T: Folate intake and colorectal cancer risk: A meta-analytical approach. International Journal of Cancer 113, 825-828, 2005.
23. Song J, Medline A, Mason J, Gallinger S, and Kim Y: Effects of dietary folate on intestinal tumorigenesis in the ApcMin mouse. Cancer Res 60, 5434-5440, 2000.
24. Charles D, Ness A, Campbell D, Davey-Smith G, and Hall M: Taking folate in pregnancy and risk of maternal breast cancer. Br Med J 329, 1375-1376, 2004.
25. ChangH, Zhang T, Zhang Z, Bao R, Fu C, et al.: Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J Nutr Biochem 22, 1172-1177, 2011.
26. Pogribny I, James S, Jernigan S, and Pogribna M: Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutat Res 548, 53-59, 2004.
27. Ghandour H, Chen Z, Selhub J, andRozen R: Mice deficient inmethylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates.JNutr 134, 2975-2978, 2004.
28. Berner C, Aumüller E, Gnauck A, Nestelberger M, Just A, et al.: Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57, 183-189, 2010.
29. Mas S, LafuenteMJ, Crescenti A, Trias M, Ballesta A, et al.: Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1. Anticancer Res 27, 1151-1156, 2007.
30. Pirouzpanah S, Taleban F, Atri M, Abadi A, and Mehdipour P: The effect of modifiable potentials on hypermethylation status of retinoic acid receptorbeta2 and estrogen receptor-alpha genes in primary breast cancer. Canc Causes Contr 21, 2101-2111, 2010.
31. Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M, Costea I, et al.: Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4, 66-72, 2004.
32. Cai DW, Liu XF, Bu RG, Chen XN, Ning L, et al.: Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in aChinese population. J IntMedRes 37, 1882-1889, 2009.
33. Supic G, Jovic N, Kozomara R, Zeljic K, andMagic Z: Interaction between the MTHFR C677T polymorphism and alcohol-impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res 90, 65-70, 2011.
34. Paz M, Avila S, Fraga M, Pollan M, Capella G, et al.: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62, 4519-4524, 2002.
35. Hamid A, Wani NA, and Kaur J: New perspectives on folate transport in relation to alcoholism-induced folate malabsorption-association with epigenome stability and cancer development. FEBS J 276, 2175-2191, 2009.
36. Khan N and Mukhtar H: Cancer and metastasis: Prevention and treatment by green tea. Cancer Metastasis Rev 29, 435-445, 2010.
37. Li Y, Chang S-C, Goldstein B, Scheider W, Cai L, et al.: Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol 35, 362-368, 2011.
38. Lu H, Meng X, Li C, Patten C, Sheng S, et al.:Glucoronides of tea catechins: Enzymology of biosynthesis and biological activities. Drug Metab Dispos 31, 452-461, 2003.
39. Fang M, Wang Y, Ai N, Hou Z, Sun Y, et al.: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63, 7563-7570, 2003.
40. Berletch J, Liu C, Love W, Andrews L, Katiyar S, et al.: Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 103, 509-519, 2008.
41. Kato K, Long N, Makita H, Toida M, Yamashita T, et al.: Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99, 647-654, 2008.
42. Gao Z, Xu Z, Hung MS, Lin YC, Wang T, et al.: Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res 29, 2025-2030, 2009.
43. Nandakumar V, Vaid M, and Katiyar SK: (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32, 537-544, 2011.
44. LiYand Tollefsbol T: Impact onDNAmethylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 17, 2141-2151, 2010.
45. Fang M, Chen D, Sun Y, Jin Z, Christman JK, et al.: Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Cancer Res 11, 7033-7041, 2005.
46. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, et al.: Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 24, 393-400, 2010.
47. Fustier P, Le Corre L, Chalabi N, Vissac-Sabatier C, Communal Y, et al.: Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumor cell lines. Br J Cancer 89, 168-172, 2003.
48. Papoutsis A, Lamore S,Wondrak G, Selmin O, and Romagnolo D: Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr 140, 1607-1614, 2010.
49. Jha A, Nikbakht M, Parashar G, Shrivastava A, Capalash N, et al.: Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha) 56, 195-200, 2010.
50. Priyadarsini R, Vinothini G, Murugan R,Manikandan P, and Nagini S: The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer 63, 218-226, 2011.
51. Wang P, Heber D, and Henning SM: Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct 3, 635-642, 2012.
52. Wang P, Heber D, and Henning S: Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr Cancer 64, 580-587, 2012.
53. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, et al.: Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682, 39-53, 2009.
54. Spurling C, Suhl J, Boucher N, Nelson C, Rosenberg D, et al.: The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARβ2 in colon cancer cells. Nutr Cancer 60, 692-702, 2008.
55. Davis C, Uthus E, and Finley J: Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 130, 2903-2909, 2000.
56. Barrera L, Cassidy A, Johnson I, Bao Y, and Belshaw N: Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: Potential implications for cancer chemoprevention. Proc Nutr Soc 6, 1-9, 2012.
57. Fiala E, Staretz M, Pandya G, El-BayoumyK, and Hamilton S: Inhibition of DNAcytosinemethyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 19, 597-604, 1998.
58. Davis C and Uthus E: Dietary selenite and azadeoxycytidine treatments affect dimethyl-hydrazine-induced aberrant crypt formation in rat colon and DNA methylation in HT-29 cells. J Nutr 132, 292-297, 2002.
59. Uthus E and Ross S: Dietary selenium affects homocysteine metabolism differently in Fisher-344 rats and CD-1 mice. J Nutr 137, 1132-1136, 2007.
60. Lippman S, Klein E, Goodman P, Lucia M, Thompson I, et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39-51, 2009.
61. Jenuwein T and Allis CD: Translating the histone code. Science 293, 1074-1080, 2001.
62. Margueron R, Trojer P, and Reinberg D: The key to development: Interpreting the histone code? Cur Opin Gen Dev 15, 163-176, 2005.
63. Mahlknecht U and Hoelzer D: Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6, 623-644, 2000.
64. Miremadi A, Oestergaard M, Pharoah P, and Caldas C: Cancer genetics of epigenetic genes. Hum Mol Genet 16, 28-49, 2007.
65. Pogribny I, Tryndyak V, Muskhelishvili L, Rusyn I, and Ross S: Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J Nutr 137, 216S-222S, 2007.
66. Jawaid K, Crane SR, Nowers JL, Lacey M, and Whitehead SA: Longterm genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. J Steroid Biochem Mol Biol 120, 164-171, 2010.
67. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, et al.: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123, 552-560, 2008.
68. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, et al.: Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68, 2736-2744, 2008.
69. Cappelletti V, Fioravanti L, Miodini P, and Di Fronzo G: Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J Cell Biochem 79, 594-600, 2000.
70. Shankar S and Srivastava R: Involvement of Bcl-2 family members, phosphatidylinositol 30-kinase-AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 30, 905-918, 2007.
71. Kang S, Cha S, and Jeon H: Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 15, 165-169, 2006.
72. Myzak M and Dashwood R: Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 7, 443-452, 2006.
73. Lu R,Wang X, Sun D, Tian X, Zhao S, et al.: Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer. Epigenetics 3, 330-335, 2008.
74. Nian H, DelageB,Ho E, and Dashwood RH:Modulation of histone deacetylases activity by dietary isothiocyanates and allyl sulfides: Studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 50, 213-221, 2009.
75. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: From cells to mice to man. Semin Cancer Biol 17, 363-369, 2007.
76. Myzak MC, Hardin K, Wang R, Dashwood RH, and Ho E: Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 27, 811-819, 2006.
77. Meeran S, Patel S, and Tollefsbol T: Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5, e11457, 2010.
78. Myzak MC, Dashwood WM, Orner GA, Ho E, and Dashwood RH: Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J. 20, 506-508, 2006.
79. Riso P, Martini D, Visioli F, Martinetti A, and Porrini M: Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers. Nutr Cancer 61, 232-237, 2009.
80. Ho E, Clarke JD, and Dashwood R: Dietary sulforaphane, a histone deacetylases inhibitor for cancer prevention. J Nutr 139, 2393-2396, 2009.
81. Myzak M, Tong P, Dashwood W, Dashwood R, and Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med 232, 227-234, 2007.
82. Nian H, DelageB,Ho E, and Dashwood RH:Modulation of histone deacetylases activity by dietary isothiocyanates and allyl sulfides: Studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 50, 213-221, 2009.
83. Nian H, Delage B, Pinto JT, and Dashwood RH: Allyl mercaptan, a garlicderived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis 29, 1816-1824, 2008.
84. Noratto G, Kim Y, Talcott S, andMertens-Talcott S: Flavonol-rich fractions of yaupon holly leaves (Ilex vomitoria, Aquifoliaceae) induce microRNA-146a and have anti-inflammatory and chemopreventive effects in intestinal myofibroblast CCD-18Co cells. Fitoterapia 82, 557-569, 2011.
85. Druesne N, Pagniez A, Mayeur C, Thomas M, Cherbuy C, et al.: Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 25, 1227-1236, 2004.
86. Druesne N, Pagniez A, Mayeur C, Thomas M, Cherbuy C, et al.: Repetitive treatments of colon HT-29 cells with diallyl disulfide induce a prolonged hyperacetylation of histone H3 K14. Ann N Y Acad Sci 1030, 612-621, 2004.
87. Shivdasani RA: MicroRNAs: Regulators of gene expression and cell differentiation. Blood 108, 3646-3653, 2006.
88. Negrini M, Ferracin M, Sabbioni S, and Croce C: MicroRNAs in human cancer: From research to therapy. J Cell Sci 120, 1833-1840, 2007.
89. Kim DH, Saetrom P, Snove O, Jr., and Rossi JJ: MicroRNA-directed transcriptional gene silencing in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 105, 16230-16235, 2008.
90. Benhamed M, Herbig U, Ye T, Dejean A, and Bischof O: Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nature Cell Biology 14, 266-275, 2012.
91. Marsit CJ, Eddy K, and Kelsey KT: MicroRNA responses to cellular stress. Cancer Res 66, 10843-10848, 2006.
92. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, et al.: Downregulation of miRNA-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99, 671-678, 2006.
93. Davis CD and Ross SA: Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev 66, 477-482, 2008.
94. Pogribny I, Tryndyak V, Ross S, and Beland F: Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutr Rev 66(Suppl. 1), S33-S35, 2008.
95. Tryndyak V, Ross S, Beland F, and Pogribny I: Down-regulation of the microRNAs miRNA-34a, miRNA-127, and miRNA-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 48, 479-487, 2009.
96. Wang L, Zhang Z, Li Q, Yang R, Pei X, et al.: Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 24, 562-579, 2009.
97. TsangWP and Kwok TT: Epigallocatechin gallate up-regulation of miRNA-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21, 140-146, 2010.
98. Sun Q, Cong R, Yan H, Gu H, Zeng Y, et al.: Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep 22, 563-567, 2009.
99. Salerno E, Scaglione B, Coffman F, Brown B, Baccarini A, et al.: Correcting miRNA-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther 8, 2684-2692, 2009.
100. Parker L, Taylor D, Kesterson J,Metzinger D, and Gercel-Taylor C: Modulation of microRNA associated with ovarian cancer cells by genistein. Eur J Gynaecol Oncol 30, 616-621, 2009.
101. Chen Y, ZamanMS, Deng G, Majid S, Saini S, et al.:MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer. Cancer Prev Res 4, 76-86, 2011.
102. Tili E, Michaille J, Alder H, Volinia S, Delmas D, et al.: Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem Pharmacol 80, 2057-2065, 2010.
103. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, et al.: Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7, 464-473, 2008.
104. Yang J, Cao Y, Sun J, and Zhang Y: Curcumin reduces the expression of Bcl-2 by upregulating miRNA-15a and miRNA-16 in MCF-7 cells. Med Oncol 27, 1114-1118, 2010.
105. Sarveswaran S, Liroff J, Zhou Z, Nikitin A, and Ghosh J: Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. Int J Oncol 36, 1419-1428, 2010.